Trial Profile

Eplerenone Combination Versus Conventional Agents to Lower Blood Pressure on Urinary Antialbuminuric Treatment Effect Trial.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 25 Aug 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Eplerenone (Primary)
Indications Hypertension
Focus Pharmacodynamics
Acronyms EVALUATE

Most Recent Events

15 Jun 2015 Results assessing dietary salt intake presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.
14 May 2015 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
14 Jun 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com